Company intelligence / Profile preview

Chemi-Pharm

Ownership: Private
Development stage: Commercial

Overview

Chemi-Pharm AS develops and manufactures disinfection agents, detergents, and evidence-based skincare products for medical and consumer use. Its portfolio includes the D’DIFFERENCE skincare line and Medihex health/pharmaceutical brand. The company exports to over 25 countries worldwide. It has conducted clinical studies on its BIOBLOCK® nasal spray for viral protection.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Non-pharmacological therapy (disinfection agents)Topical products (skincare)Device (nasal spray)
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with researchers/universities for product development (e.g., Medihex brand)

Beyond the preview

Go deeper on Chemi-Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemi-Pharm.

Explore the full profile